Aimmune Therapeutics Company Profile (NASDAQ:AIMT)

About Aimmune Therapeutics

Aimmune Therapeutics logoAimmune Therapeutics Inc, formerly Allergen Research Corporation, is a United States-based clinical-stage biopharmaceutical company. The Company focuses on therapeutic approach, including the development of proprietary candidates, for the treatment of peanut and other food allergies. The Company's Characterized Oral Desensitization Immunotherapy (CODIT) is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols and support services. Its lead product, AR101, which has completed a Phase II study, is designed to treat peanut allergy. The Company's AR101 is a mixture of naturally occurring proteins and pharmaceutical-grade ingredients. Its CODIT system aims to improve upon oral immunotherapy (OIT) by precisely controlling the amount of food protein administered and establishing very gradual treatment regimens that begin with low doses of protein.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AIMT
  • CUSIP:
Key Metrics:
  • Previous Close: $15.15
  • 50 Day Moving Average: $12.01
  • 200 Day Moving Average: $13.77
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.11
  • P/E Growth: 0.20
  • Market Cap: $640.15M
  • Outstanding Shares: 42,254,000
Additional Links:
Companies Related to Aimmune Therapeutics:

Analyst Ratings

Consensus Ratings for Aimmune Therapeutics (NASDAQ:AIMT) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $37.75 (149.17% upside)

Analysts' Ratings History for Aimmune Therapeutics (NASDAQ:AIMT)
Show:
DateFirmActionRatingPrice TargetDetails
8/24/2016WedbushReiterated RatingBuy$42.00View Rating Details
8/19/2016Credit Suisse Group AGReiterated RatingBuy$35.00View Rating Details
6/29/2016Piper Jaffray Cos.Reiterated RatingOverweight$38.00View Rating Details
5/16/2016Bank of America Corp.Reiterated RatingBuyView Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for Aimmune Therapeutics (NASDAQ:AIMT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/10/2016Q216($0.42)($0.43)ViewN/AView Earnings Details
5/16/2016Q116($0.40)($0.37)ViewN/AView Earnings Details
3/3/2016Q415($0.35)($0.39)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aimmune Therapeutics (NASDAQ:AIMT)
Current Year EPS Consensus Estimate: $-1.7 EPS
Next Year EPS Consensus Estimate: $-2.13 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.28)($0.28)($0.28)
Q2 20161($0.39)($0.39)($0.39)
Q3 20161($0.44)($0.44)($0.44)
Q4 20161($0.45)($0.45)($0.45)
Q1 20171($0.48)($0.48)($0.48)
Q2 20171($0.50)($0.50)($0.50)
Q3 20171($0.52)($0.52)($0.52)
Q4 20171($0.54)($0.54)($0.54)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aimmune Therapeutics (NASDAQ:AIMT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aimmune Therapeutics (NASDAQ:AIMT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/31/2016Foresite Capital Fund Ii, L.P.Major ShareholderSell240,000$15.23$3,655,200.00View SEC Filing  
3/29/2016Longitude Capital Partners Ii,Major ShareholderBuy78,504$13.87$1,088,850.48View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aimmune Therapeutics (NASDAQ:AIMT)
DateHeadline
streetinsider.com logoAimmune Therapeutics (AIMT): Expecting Success In Palisades Trial - Piper Jaffray - StreetInsider.com (NASDAQ:AIMT)
www.streetinsider.com - August 23 at 8:55 AM
live-pr.com logoNewly released market study: Aimmune Therapeutics, Inc. (AIMT) - Financial and Strategic SWOT Analysis Review (NASDAQ:AIMT)
www.live-pr.com - August 22 at 8:11 AM
biz.yahoo.com logoAimmune Therapeutics Inc Call to Discuss the Publication of the DEVIL study data and potential implications for development of AR101 scheduled for 4:30 pm ET today (NASDAQ:AIMT)
biz.yahoo.com - August 22 at 8:11 AM
finance.yahoo.com logoAIMMUNE THERAPEUTICS, INC. Financials (NASDAQ:AIMT)
finance.yahoo.com - August 20 at 3:25 PM
News IconNews review of 2 biotech stocks: Aimmune Therapeutics, Inc. (NASDAQ:AIMT), Raptor Pharmaceuticals Corp ... - The Voice Registrar (NASDAQ:AIMT)
voiceregistrar.com - August 20 at 8:22 AM
News IconActive News in Reviews- OncoMed Pharmaceuticals (OMED), Aimmune Therapeutics (AIMT), Cardinal Financial (CFNL) - Seneca Globe (NASDAQ:AIMT)
www.senecaglobe.com - August 19 at 11:49 AM
finance.yahoo.com logo8:02 am Aimmune Therapeutics will host call to discuss the results of an independent academic clinical trial demonstrating the ability of low-dose oral immunotherapy to induce unresponsiveness in peanut-allergic children (NASDAQ:AIMT)
finance.yahoo.com - August 18 at 11:48 AM
publicnow.com logoAimmune Therapeutics to Host Conference Call on Potential Positive Implications for AR101 Development From Independent Academic Study Showing Oral Immunotherapy Induces Sustained Unresponsiveness in Young Peanut-Allergic Children (NASDAQ:AIMT)
www.publicnow.com - August 18 at 11:48 AM
marketexclusive.com logoAimmune Therapeutics Inc (NASDAQ:AIMT) Is Bringing A 100 Year Old Treatment Into The 21st Century - Market Exclusive (NASDAQ:AIMT)
marketexclusive.com - August 16 at 3:25 PM
insidermonkey.com logoAimmune Therapeutics Inc (AIMT) Is Bringing A 100 Year Old Treatment Into The 21st Century (NASDAQ:AIMT)
www.insidermonkey.com - August 16 at 3:25 PM
marketexclusive.com logoAimmune Therapeutics Inc (NASDAQ:AIMT) Is Bringing A 100 Year Old Treatment Into The 21st Century (NASDAQ:AIMT)
marketexclusive.com - August 16 at 11:59 AM
kcregister.com logoWorth Watching Stocks: Aimmune Therapeutics, Inc. (NASDAQ:AIMT), Pernix Therapeutics Holdings, Inc. (NASDAQ ... - KC Register (NASDAQ:AIMT)
www.kcregister.com - August 15 at 10:39 AM
News IconAimmune Announces Second Quarter 2016 Financial Results (NASDAQ:AIMT)
www.biospace.com - August 11 at 9:16 PM
sg.finance.yahoo.com logoAimmune Therapeutics reports 2Q loss (NASDAQ:AIMT)
sg.finance.yahoo.com - August 10 at 9:50 PM
publicnow.com logoAimmune Therapeutics Announces Second Quarter 2016 Financial Results (NASDAQ:AIMT)
www.publicnow.com - August 10 at 9:50 PM
finance.yahoo.com logoAimmune Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:AIMT)
finance.yahoo.com - August 9 at 12:09 PM
News IconAimmune Therapeutics Inc Can't Burn Your Long Portfolio. Has Another Strong Session - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 22 at 8:24 PM
News IconAimmune Therapeutics Inc Gaps Up; Strong Momentum for Buyers - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 22 at 3:22 PM
News IconStock Moving Lower for the Month; Investor Update on Aimmune Therapeutics, Inc. (NASDAQ:AIMT) - Engelwood Daily (NASDAQ:AIMT)
www.engelwooddaily.com - July 21 at 3:22 PM
News IconAimmune Therapeutics Inc's Stock Is Buy After Today's Huge Increase - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 21 at 3:22 PM
News IconAimmune Therapeutics Incorporated (NASDAQ:AIMT) Shorted Shares Increased 23.82% After Market Selling - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 19 at 3:24 PM
News IconIncreased Volatility Noted on Shares of: Aimmune Therapeutics, Inc. (NASDAQ:AIMT) - Engelwood Daily (NASDAQ:AIMT)
www.engelwooddaily.com - July 16 at 3:22 PM
News IconIncreased Volatility Noted on Shares of: Aimmune Therapeutics, Inc. (NASDAQ:AIMT) - Engelwood Daily (NASDAQ:AIMT)
www.engelwooddaily.com - July 16 at 3:22 PM
News IconHow Many Aimmune Therapeutics Inc (NASDAQ:AIMT)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 16 at 3:22 PM
News IconHow Many Aimmune Therapeutics Inc (NASDAQ:AIMT)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 16 at 3:22 PM
News IconAimmune Therapeutics Incorporated (NASDAQ:AIMT) Shorted Shares Increased 2.16% After Market Selling - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 16 at 3:22 PM
News IconAimmune Therapeutics Incorporated (NASDAQ:AIMT) Shorted Shares Increased 2.16% After Market Selling - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 16 at 3:22 PM
News IconShares Losing Ground for the Month; Investor Alert on Aimmune Therapeutics, Inc. (NASDAQ:AIMT) - Engelwood Daily (NASDAQ:AIMT)
www.engelwooddaily.com - July 14 at 12:18 PM
News IconEye on Stock Volatility for: Aimmune Therapeutics, Inc. (NASDAQ:AIMT) - Engelwood Daily (NASDAQ:AIMT)
www.engelwooddaily.com - July 14 at 12:18 PM
News IconAimmune Therapeutics Incorporated (NASDAQ:AIMT) Sellers Increased By 2.16% Their Shorts - Consumer Eagle (NASDAQ:AIMT)
www.consumereagle.com - July 13 at 11:28 AM
fiscalstandard.com logoAimmune Therapeutics, Inc. (NASDAQ:AIMT) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:AIMT)
www.fiscalstandard.com - July 11 at 8:11 AM
News IconAimmune Therapeutics Incorporated (NASDAQ:AIMT) Short Interest Increased By 2.16% - Press Telegraph (NASDAQ:AIMT)
presstelegraph.com - July 9 at 3:22 PM
kcregister.com logoHealthcare New Lows: Aimmune Therapeutics, Inc. (NASDAQ:AIMT), Great Basin Scientific, Inc. (NASDAQ:GBSN ... - KC Register (NASDAQ:AIMT)
www.kcregister.com - July 8 at 11:26 AM
News IconHow Analysts Feel About Aimmune Therapeutics Inc (NASDAQ:AIMT)? - Press Telegraph (NASDAQ:AIMT)
presstelegraph.com - July 8 at 11:26 AM
fiscalstandard.com logoAimmune Therapeutics, Inc. (NASDAQ:AIMT) Current Analyst Ratings - Fiscal Standard (NASDAQ:AIMT)
www.fiscalstandard.com - July 6 at 8:11 AM
finance.yahoo.com logoAimmune Therapeutics to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:AIMT)
finance.yahoo.com - July 5 at 8:00 AM
News IconCompany Stock Lower on the Week Aimmune Therapeutics, Inc. (NASDAQ:AIMT) - Engelwood Daily (NASDAQ:AIMT)
www.engelwooddaily.com - July 2 at 11:05 AM
kcregister.com logoMarket Movers: Aimmune Therapeutics (NASDAQ:AIMT), Insmed Incorporated (NASDAQ:INSM), Infoblox Inc. (NYSE ... - KC Register (NASDAQ:AIMT)
www.kcregister.com - July 1 at 3:24 PM
News IconHow Analysts Rated Aimmune Therapeutics Inc (NASDAQ:AIMT) Last Week? - Engelwood Daily (NASDAQ:AIMT)
www.engelwooddaily.com - July 1 at 3:24 PM
kcregister.com logoSmall Cap New Lows: Aimmune Therapeutics. (NASDAQ:AIMT), Waddell & Reed Financial, Inc. (NYSE:WDR ... - KC Register (NASDAQ:AIMT)
www.kcregister.com - June 28 at 3:38 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Aimmune Therapeutics, Inc. (NASDAQ:AIMT) - Fiscal Standard (NASDAQ:AIMT)
www.fiscalstandard.com - June 27 at 8:09 AM
ftsenews.co.uk logoAimmune Therapeutics, Inc. (NASDAQ:AIMT) Updated Price Targets - FTSE News (NASDAQ:AIMT)
www.ftsenews.co.uk - June 24 at 3:23 PM
fidaily.com logoAimmune Therapeutics, Inc. (AIMT) Reached a 52-Week Low - Finance Daily (NASDAQ:AIMT)
www.fidaily.com - June 24 at 3:23 PM
biz.yahoo.com logoAIMMUNE THERAPEUTICS, INC. Files SEC form 8-K, Other Events (NASDAQ:AIMT)
biz.yahoo.com - June 21 at 4:06 PM
streetinsider.com logoAimmune Therapeutics (AIMT) Names Daniel Adelman M.D. as Chief Medical Officer - StreetInsider.com (NASDAQ:AIMT)
www.streetinsider.com - June 21 at 8:09 AM
publicnow.com logoAimmune Therapeutics Appoints Daniel Adelman, M.D., as Chief Medical Officer (NASDAQ:AIMT)
www.publicnow.com - June 21 at 7:19 AM
fiscalstandard.com logoAnalyst Views For The Week Ahead: Aimmune Therapeutics, Inc. (NASDAQ:AIMT) - Fiscal Standard (NASDAQ:AIMT)
www.fiscalstandard.com - June 20 at 9:53 AM
fidaily.com logoAimmune Therapeutics, Inc. (AIMT) Trades at 52-Week Low - Finance Daily (NASDAQ:AIMT)
www.fidaily.com - June 16 at 3:23 PM
biz.yahoo.com logoAimmune Therapeutics Inc Management Conference Call on Late-Breaker Presentation at the EAACI scheduled for 4:00 pm ET today (NASDAQ:AIMT)
biz.yahoo.com - June 13 at 4:00 PM
streetinsider.com logoAimmune Therapeutics (AIMT) Announces New Data on AR101 Phase 2; Low-Dose Regimen Supported - StreetInsider.com (NASDAQ:AIMT)
www.streetinsider.com - June 13 at 3:23 PM

Social

Aimmune Therapeutics (NASDAQ:AIMT) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff